Thromboembolic disease in advanced colorectal cancer treated with chemotherapy and bevacizumab: a case of real "pan-thrombosis"

被引：1
作者：
Giuliani, Jacopo [1 ]
Martelli, Salvatore [2 ]
Piacentini, Paolo [1 ]
Bonetti, Andrea [1 ]
机构：
[1] ASL 21 Reg Veneto, Dept Oncol, Mater Salutis Hosp, I-37045 Legnago Verona, Italy
[2] ASL 21 Reg Veneto, Dept Radiol, Mater Salutis Hosp, I-37045 Legnago Verona, Italy
来源：
TUMORI | 2015年 / 101卷 / 01期
关键词：
PLUS BEVACIZUMAB; POOLED ANALYSIS; OXALIPLATIN; FLUOROURACIL; LEUCOVORIN; THERAPY; EVENTS;
D O I：
10.5301/tj.5000258
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E32 / E33
页数：2
相关论文
共 50 条
  • [31] Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab
    Koutras, A. K.
    Antonacopoulou, A. G.
    Eleftheraki, A. G.
    Dimitrakopoulos, F-I
    Koumarianou, A.
    Varthalitis, I.
    Fostira, F.
    Sgouros, J.
    Briasoulis, E.
    Bournakis, E.
    Bafaloukos, D.
    Bompolaki, I.
    Galani, E.
    Kalogeras, K. T.
    Pectasides, D.
    Fountzilas, G.
    Kalofonos, H. P.
    PHARMACOGENOMICS JOURNAL, 2012, 12 (06) : 468 - 475
  • [32] Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study)
    Kotaka, Masahito
    Iwamoto, Shigeyoshi
    Satake, Hironaga
    Sakai, Daisuke
    Kudo, Toshihiro
    Fukunaga, Mutsumi
    Konishi, Ken
    Ide, Yoshihito
    Ikumoto, Taro
    Tsuji, Akihito
    Sano, Yasushi
    Kato, Takeshi
    Sugimoto, Naotoshi
    Satoh, Taroh
    Kanazawa, Akiyoshi
    Kurata, Takayasu
    Yamanaka, Takeharu
    Tomita, Naohiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (08) : 1515 - 1522
  • [33] Combined treatment with Bevacizumab and standard chemotherapy restores abnormal immune parameters in advanced colorectal cancer patients
    Nikolaos Tsavaris
    Ioannis F. Voutsas
    Christos Kosmas
    Angelos D. Gritzapis
    Constantin N. Baxevanis
    Investigational New Drugs, 2012, 30 : 395 - 402
  • [34] Tumor calcification is associated with better survival in metastatic colorectal cancer patients treated with bevacizumab plus chemotherapy
    Zhou, Yu-Wen
    Long, Yi-Xiu
    Liu, Xia
    Liu, Ji-Yan
    Qiu, Meng
    FUTURE ONCOLOGY, 2022, 18 (22) : 2453 - 2464
  • [35] Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy
    Cybulska-Stopa, Bozena
    Lugowska, Iwona
    Wisniowski, Rafal
    Domagala-Haduch, Malgorzata
    Rajczykowski, Marcin
    Piejko, Karolina
    Bar-Letkiewicz, Ilona
    Suwinski, Rafal
    Regulski, Krzysztof
    Mackiewicz, Jacek
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2020, 24 (01): : 34 - 41
  • [36] Efficacy of Oxaliplatin-based Chemotherapy plus Bevacizumab as First-line Treatment for Advanced Colorectal Cancer A Systematic Review and Pooled Analysis of Published Trials
    Petrelli, Fausto
    Coinu, Andrea
    Ghilardi, Mara
    Cabiddu, Mary
    Zaniboni, Alberto
    Barni, Sandro
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (02): : 227 - 233
  • [37] Case report: Changes in serum bevacizumab concentration in a hemodialysis patient with unresectable colorectal cancer treated with FOLFIRI plus bevacizumab
    Tanaka, Toshimitsu
    Suzuki, Hiroyuki
    Ushijima, Tomoyuki
    Nagasu, Sachiko
    Akagi, Yoshito
    Kawaguchi, Takumi
    Miwa, Keisuke
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [38] Therapeutic Significance of a D-dimer Cut-off Level of >3 μg/ml in Colorectal Cancer Patients Treated with Standard Chemotherapy plus Bevacizumab
    Mochizuki, Satoshi
    Yoshino, Takayuki
    Kojima, Takashi
    Fuse, Nozomu
    Ikematsu, Hiroaki
    Minashi, Keiko
    Yano, Tomonori
    Tahara, Makoto
    Kaneko, Kazuhiro
    Doi, Toshihiko
    Koike, Kazuhiko
    Ohtsu, Atsushi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (10) : 933 - 937
  • [39] The role of tiopronin for the prevention of chemotherapy-related liver toxicity in advanced colorectal cancer patients treated with mFOLFOX7: a prospective analysis
    Li, Xiao-peng
    Wen, Feng
    Yang, Wu
    Deng, Yi-bo
    Li, Meng
    Zhang, Peng-fei
    Tang, Rui-lei
    Li, Qiu
    Wei, Yu-quan
    TUMORI JOURNAL, 2014, 100 (04): : 446 - 451
  • [40] FOLFIRI-Bevacizumab As First-Line Chemotherapy in 3500 Patients With Advanced Colorectal Cancer: A Pooled Analysis of 29 Published Trials
    Petrelli, Fausto
    Borgonovo, Karen
    Cabiddu, Mary
    Ghilardi, Mara
    Lonati, Veronica
    Maspero, Federica
    Sauta, Maria Grazia
    Beretta, Giordano Domenico
    Barni, Sandro
    CLINICAL COLORECTAL CANCER, 2013, 12 (03) : 145 - 151
12345